RTX delivered solid Q3 2026 results with double-digit organic sales growth and robust free cash flow, lifting full-year targets. A record backlog of $340B and over $81B in new awards underscore durable demand across Collins Aerospace, Pratt & Whitney, and Raytheon segments. The company cites IEEPA-related cost recovery and ongoing cost optimization driving higher earnings and cash generation.
RTX is slated to report Q3 results Oct 20, with consensus EPS of $1.77 on $24.05B revenue. Separately, Raytheon unit won $729M in counter-drone contracts, underscoring defense exposure. Analysts show mixed ratings but sizeable upside targets; the stock rose about 1.7% ahead of the print as investors weigh earnings and backlog momentum.
RTX's Raytheon unit secured a five-year contract with two option years for up to $6.3 billion to produce and sustain SM-3 Block IB interceptors. The deal expands capacity at Tucson and Huntsville, reinforcing a combat-proven defense program and improving long-term revenue visibility amid rising U.S. missile-defense needs.
The U.S. Navy awarded Raytheon Technologies' Raytheon unit a multiyear deal worth up to $24.4 billion to produce Standard Missile-6 interceptors, as the Pentagon seeks to replenish munitions stockpiles depleted by Middle East conflicts. The contract extends revenue visibility into multiple years and reinforces RTX's position in strategic weapons, likely supporting near-term cash flow and backlog growth.
RTX's Raytheon unit won a five-year, up to $20.7B contract to accelerate AMRAAM production under the Arsenal of Freedom. The deal strengthens revenue visibility, supports backlog growth, and signals robust demand for US air defense interceptors, with international co-production discussions potentially broadening the addressable market.
The European Commission has closed its antitrust investigation into RTX's Pratt & Whitney Canada Corp., with no penalties disclosed. The ruling removes European regulatory overhang tied to the unit's competitive practices, trimming RTX's legal/risk tail in Europe and potentially lifting sentiment modestly. The impact on earnings is likely limited, but the relief could support near-term stock performance.